Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Pharmacol Res. 2021 May 4;169:105653. doi: 10.1016/j.phrs.2021.105653

Fig. 3. Functional properties displayed by Zn2+ and H+ at WT ZAC (ZACThr128) expressed in oocytes.

Fig. 3.

A. Agonist properties of Zn2+. Representative traces for Zn2+-evoked currents (left) and averaged concentration-response relationship displayed by Zn2+ at ZAC (means ± S.E.M., n = 6) (right). B. Agonist properties of H+. Representative traces for H+-evoked currents (left) and averaged “low-potency” and “high-potency” concentration-response relationships displayed by H+ at ZAC (right) (means ± S.E.M., n = 6–7) (right). The “low-potency” and “high-potency” data are normalised to the IpH 3.5 value and to the fitted Imax value, respectively. C. Representative traces for currents evoked by prolonged applications of Zn2+ (1 mM) and H+ (pH 4.5) at ZAC. D. Current-voltage (IV) relationship of Zn2+-evoked currents through ZAC. Representative traces for currents evoked by prolonged application of Zn2+ (1 mM) at different holding potentials (left) and averaged IV relationship exhibited by Zn2+ (1 mM) at ZAC (right). Current amplitudes are plotted against clamped holding potentials, and data are given as leak-subtracted average current amplitudes normalised to the amplitude of currents recorded at − 60 mV (mean ± S.E.M., n = 6).